The popular weight-loss drugs Ozempic and Wegovy may be available in pill form by as soon as the end of this year. Manufacturers are racing to be the first to market with an oral version of the newest class of weight-loss drugs that already have earned billions in profits as injectables.

"The nice thing about tablets is that virtually everyone is used to taking a tablet for something, even if it's just a vitamin," said Dr. Robert Gabbay, chief scientist for the American Diabetes Association. "It's not a big deal."

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.